UnitedHealth agrees to $1.8M settlement over robocall complaint

UnitedHealth Group has agreed to pay nearly $1.8 million to resolve a class action lawsuit brought against its subsidiary Optum, alleging the company used illegal robocalls to push home healthcare services, including prescription delivery and telemedicine. 

A lawsuit claimed the company used artificial, prerecorded voice messages sent by robo dialers to advertise Optum at Home, even to people who were not signed up to receive calls, regardless of whether or not those on the receiving end opted out. 

This constituted a violation of the Telephone Consumer Protection Act (TCPA), plaintiffs alleged. 

Although UnitedHealth agreed to the settlement, the company does not admit to any wrongdoing in making the calls, which reportedly occurred between Dec. 11, 2019, and March 27, 2025. 

The primary plaintiff bringing the case, which was given class-action status, said he received ongoing calls from Optum, despite never giving permission for any company related to UnitedHealthcare to contact him. 

Anyone who received the unwanted spam calls can sign up to receive part of the settlement fund, the deadline for filing set for June 24. A website has been set up to manage claimant responses. 

The court date has been scheduled to fully resolve the case. That hearing is scheduled for Aug. 4. 

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

The company has agreed to acquire Verve Therapeutics for an upfront payment of approximately $1 billion. The total could increase significantly, however, if certain milestones are met. One of Verve's biggest gene therapies has already received the FDA's fast track designation.

American College of Cardiology Board of Governors Chair David E. Winchester, MD, MS, examines the many benefits of working with the American Medical Association House of Delegates to bring about significant change.

“Without a more concrete and stable policy on these tariffs from the current American administration, it is likely that most manufacturers will be forced to continuously change their internal forecasts and production plans," one analyst said.